BioCentury
ARTICLE | Financial News

Vaccinex down following $40M IPO

August 9, 2018 7:40 PM UTC

Vaccinex Inc. (NASDAQ:VCNX) lost $0.62 to $11.38 Thursday after it raised $40 million through the sale of 3.3 million shares at $12 in an IPO underwritten by Oppenheimer, BTIG and Ladenburg. The offering values the company at $137.7 million.

Vaccinex priced the offering at the low end of its $12-$15 range. At the midpoint of $13.50, the offering would have valued Vaccinex at $154.9 million...

BCIQ Company Profiles

Vaccinex Inc.

BCIQ Target Profiles

Semaphorin 4D (SEMA4D)